Home|Best-Bschool-in-india-2018

DSIJ Mindshare

This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen' This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

Shares of the company zoomed on getting CEP approval to manufacture Ibuprofen from the Vishakhapatnam facility.

DSIJ Intelligence 0 13283 Article rating: 4.0

Solara Active Pharma Sciences (Solara) has received ‘Certificate of Suitability (CEP) approval for its new state-of-the-art multipurpose API manufacturing facility at Vishakhapatnam.

Read more
After a sharp decline, this chemical company stock bounced back in just two trading sessions After a sharp decline, this chemical company stock bounced back in just two trading sessions

After a sharp decline, this chemical company stock bounced back in just two trading sessions

Shares of the company gained around 10 per cent in just two days.

DSIJ Intelligence 1 7658 Article rating: 4.1

Shares of TGV Sraac opened today at Rs 158.50, up by roughly 4 per cent from the previous closing. After a sharp fall in the stock price on October 24 to Rs 143.60, the stock bounced back by 10 per cent in just two trading sessions.

Read more
RSS
123578910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList